Clinical Trial Update: Tinostamustine Conditioning and Autologous Stem Cell [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of tinostamustine conditioning with autologous stem cell transplantation in relapsed or progressing multiple myeloma; trial terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Tinostamustine (tinostamustine)

Snippet

Sponsor: Mundipharma-EDO GmbH | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-18